| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3851077 | American Journal of Kidney Diseases | 2009 | 11 Pages |
Abstract
Our data support that KEEP, as a targeted screening program, is a more enriched population with CKD and comorbid diabetes than NHANES. In addition, our findings highlight the relationship between dysglycemia and early stages of unidentified CKD.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Adam DO, MSPH, James R. MD, Peter A. MD, MPH, Tricia MS, Samy I. MD, MPH, Shu-Cheng MS, Suying PhD, Changchun MS, Allan J. MD, George L. MD, KEEP Investigators KEEP Investigators,